Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/INM/Operating income

INMED PHARMACEUTICALS INC. (INM) Operating income 2021–2023

INMED PHARMACEUTICALS INC. (INM) annual operating income history from SEC filings — each fiscal year as reported.

-$7.9MFY2023 · since FY2021: -$10.2M → -$7.9M
212223
Fiscal yearValueYoY
FY2023-$7.9M+57.3%
FY2022-$18.6M-82.3%
FY2021-$10.2M—

Source: SEC XBRL filings · For reference only · Not investment advice

More INM financial trends

INM RevenueINM Net incomeINM Net marginINM Gross profitINM Gross marginINM Operating marginINM Operating cash flowINM Free cash flowINM Capital expendituresINM Return on equityINM Stock buybacksINM Dividends paidINM Total assetsINM Total liabilitiesINM Shareholders’ equityINM overview →